Capital International, Inc. Seagen Inc. Transaction History

Capital International, Inc.

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$191.51 - $216.16 $9.41 Million - $10.6 Million	-49,135 Reduced 61.94%	30,189 $6.4 Million
Q2 2023 Aug 11, 2023	SELL	$187.64 - $206.25 $37.3 Million - $41 Million	-198,955 Reduced 71.49%	79,324 $15.3 Million
Q1 2023 May 15, 2023	SELL	$127.59 - $203.08 $1.76 Million - $2.81 Million	-13,824 Reduced 4.73%	278,279 $56.3 Million
Q4 2022 Feb 14, 2023	SELL	$117.37 - $139.17 $428,048 - $507,552	-3,647 Reduced 1.23%	292,103 $37.5 Million
Q3 2022 Nov 14, 2022	SELL	$135.27 - $180.11 $31.2 Million - $41.5 Million	-230,516 Reduced 43.8%	295,750 $40.5 Million

Q2 2022 Aug 15, 2022	SELL	$108.81 - $179.33 $431,322 - $710,864	-3,964 Reduced 0.75%	526,266 $93.1 Million
Q1 2022 May 16, 2022	BUY	$119.61 - $157.85 $1.75 Million - $2.31 Million	14,622 Added 2.84%	530,230 $76.4 Million
Q4 2021 Feb 14, 2022	SELL	$142.57 - $190.86 $437,262 - $585,367	-3,067 Reduced 0.59%	515,608 $79.7 Million
Q3 2021 Nov 15, 2021	SELL	$142.45 - $169.82 $12 Million - $14.3 Million	-84,240 Reduced 13.97%	518,675 $88.1 Million
Q2 2021 Aug 16, 2021	SELL	$135.08 - $161.1 $5.14 Million - $6.13 Million	-38,059 Reduced 5.94%	602,915 $95.2 Million
Q1 2021 May 14, 2021	SELL	$137.51 - $190.8 $9.5 Million - $13.2 Million	-69,122 Reduced 9.73%	640,974 $89 Million
Q4 2020 Feb 16, 2021	BUY	$164.63 - $211.93 $117 Million - $150 Million	710,096 New	710,096 $124 Million

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Capital International, Inc., based on Form 13F filings with the SEC.

Stay updated on Capital International, Inc. with notifications on news.